10x Genomics, Inc. 8-K Filing: Key Corporate Updates & Stock Information

$TXG
Form 8-K
Filed on: 2025-02-12
Source
10x Genomics, Inc. 8-K Filing: Key Corporate Updates & Stock Information

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Filing Type: The document is an 8-K filing, which is typically used to report major events that shareholders should know about.
  2. Entity Information:
  • Company Name: 10x Genomics, Inc.
  • CIK (Central Index Key): 0001770787
  • IRS Employer Identification Number (EIN): 45-5614458
  • Address: 6230 Stoneridge Mall Road, Pleasanton, CA 94588
  • Phone Number: 925-401-7300
  1. Stock Information:
  • Class of Stock: Class A common stock
  • Par Value: $0.00001 per share
  • Ticker Symbol: TXG
  • Exchange: NASDAQ
  1. Reporting Period: The filing reflects information for a specific date - February 12, 2025.
  2. Context and Schema Reference: The document follows the XBRL (eXtensible Business Reporting Language) format for reporting and references a specific schema (txg-20250212.xsd).
  3. Language and Encoding: The report is in English (en-US) and encoded in UTF-8.

Overall, this filing conveys essential corporate details about 10x Genomics, Inc., including its stock structure, contact information, and the regulatory context of the filing. Additional details from the main content of the 8-K would be necessary to understand the specific events or changes being reported.